Close Menu

You may find more results for this query on our sister sites: GenomeWeb and 360Dx.

Home › Resources › Webinars › The Case for a Universal FLT3 Assay
July 25, 2019

The Case for a Universal FLT3 Assay

Partner Webinar

Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

This on-demand webinar from Invivoscribe describes the advantages of using a highly validated and precise companion diagnostic in the assessment of FLT3 mutations in AML patients.

Dec
02
Featured Webinar

PIK3CA Mutations in Advanced Breast Cancer: The Vital Role of Tissue and Plasma Companion Diagnostics

Sponsored by
Qiagen

The Phosphoinositide 3-Kinase (PI3K) pathway is one of the most frequently altered pathways in human cancer and plays a significant role in disease progression and resistance to endocrine therapy.

What's Popular?

In Cancer

  1. Genentech, OneOncology Partner on Genomic Profiling for Personalized Cancer Care

  2. SEngine Precision Medicine IDs Potential Ovarian Cancer Treatment Combos Using Organoid Approach

    Premium

  3. Persephone Biosciences Launches Study to Assess Microbiome's Role in Cancer Treatment Response

  4. FDA Accepts Invitae Premarket Approval Submission for Stratafide Companion Diagnostic

  5. Tumor, Germline Testing of Cancer Patients Can Give Discordant Results

    Premium

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.